An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.

6798666

Washington

District of Columbia

United States

New vaccine shows promise for patients with aggressive breast cancer

Although many breast cancers can be diagnosed at an early stage with the advancement of screening technology, some types of breast cancer are highly invasive and easily metastatic, and have long lacked effective treatment options. The new anticancer drug ADCs has changed this situation and brought hope to patients with refractory breast cancer.

雖然隨著篩檢技術的進步，很多乳癌可在早期診斷出來，但有些類型的乳癌侵襲性強、易轉移，長久以來缺乏有效的治療選項。而新型抗癌藥物ADCs改變了這種狀況，為難治性乳癌患者帶來了希望。

ADCs療法令「最惡乳癌」患者存活期翻倍 | 抗體藥物偶聯物 | 乳癌新療法 | 三陰性乳癌

大纪元 Epoch Times

Falun Gong

ADCs therapy doubles the survival of patients with the “most aggressive breast cancer” | Antibody-drug conjugates | New breast cancer treatment | Triple-negative breast cancer

Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive results in a clinical trial.

All Sides

Media Bias/Fact Check

Daily Record

Reach plc

Glasgow

Glasgow City

Scotland

United Kingdom

Breast cancer break through as new vaccine shows 'promise' in treating aggressive form

NEW YORK, Nov 16 — A small trial of an experimental vaccine has shown promising results for patients with the most aggressive type of breast cancer, according to a report published on Thursday in Genome Medicine. Eighteen patients newly diagnosed with triple-negative breast cancer that had not yet spread to other organs received three doses of the personalised vaccine after undergoing standard chemotherapy and surgery to remove the tumour. Three…

Malay Mail

Dato’ Siew Ka Wei

Selangor

Malaysia

Vaccine shows early promise against aggressive breast cancer

Ad Fontes Media

News World Communications

Medical Xpress

New therapeutic vaccine gives hope against an aggressive breast cancer

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

News Medical

Ian Birkby

New vaccine shows potential in preventing recurrence of triple-negative breast cancer

In test conditions the drug meant almost everyone who had it remained cancer-free after three years

Gloucestershire Live

Gloucester

Gloucestershire

England

New jab could 'cure' aggressive breast cancer after positive results

Triple negative breast cancer is considered aggressive as it is rapidly developing and difficult to treat.An experimental vaccine, even in the first phase of clinical trials, has given promising results to prevent the recurrence of this type of tumour.The phase 1 clinical trial included 18 patients diagnosed with non-metastatic triple negative breast cancer, of whom 14 showed an immune response to the vaccine and, after three years, 16 remained …

El cáncer de mama triple negativo se considera agresivo al ser de rápido desarrollo y difícil de tratar. Una vacuna experimental, aún en la primera fase de ensayos clínicos, ha dado resultados prometedores para prevenir la reaparición de este tipo de tumores.El ensayo clínico en fase 1 incluyó a 18 pacientes diagnosticadas de cáncer de mama triple negativo no metastásico, de las que 14 mostraron una respuesta inmunitaria a la vacuna y, al cabo d…

¿Vacuna para el cáncer de mama agresivo? Primer ensayo da resultados prometedores

El Financiero

Mexico

Vacuna for Aggressive Breast Cancer? First Trial Gives Promising Results

Newswise Latest News: up-to-the-minute news, press releases, and expert sources for journalists in science, health, medicine, life news, and business

Newswise

Charlottesville

Albemarle County

Virginia

Newswise Latest News: news and press releases in science, medicine, life, and business

New vaccine shows promise for patients with aggressive breast cancer

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics